HSP90AA1 and breast cancer: With inverse correlation to the total expression level, the glutathionylated status of Hsp90 can subsequently enhance its degradation to impede the binding of Hsp90 with its client proteins, thereby correlating with favorable prognosis in breast cancer treatment [97].